Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Effective treatment of respiratory alphaherpesvirus infection using RNA interference.

Fulton A, Peters ST, Perkins GA, Jarosinski KW, Damiani A, Brosnahan M, Buckles EL, Osterrieder N, Van de Walle GR.

PLoS One. 2009;4(1):e4118. doi: 10.1371/journal.pone.0004118. Epub 2009 Jan 5.

2.

The effect of siRNA treatment on experimental equine herpesvirus type 1 (EHV-1) infection in horses.

Brosnahan MM, Damiani A, van de Walle G, Erb H, Perkins GA, Osterrieder N.

Virus Res. 2010 Feb;147(2):176-81. doi: 10.1016/j.virusres.2009.10.017. Epub 2009 Nov 5.

PMID:
19896512
3.

Evaluation of metaphylactic RNA interference to prevent equine herpesvirus type 1 infection in experimental herpesvirus myeloencephalopathy in horses.

Perkins GA, Van de Walle GR, Pusterla N, Erb HN, Osterrieder N.

Am J Vet Res. 2013 Feb;74(2):248-56. doi: 10.2460/ajvr.74.2.248.

PMID:
23363350
4.

Comparison of the pathogenesis of acute equine herpesvirus 1 (EHV-1) infection in the horse and the mouse model: a review.

Walker C, Love DN, Whalley JM.

Vet Microbiol. 1999 Aug 16;68(1-2):3-13. Review.

PMID:
10501157
5.

Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.

Weerasinghe CU, Learmonth GS, Gilkerson JR, Foote CE, Wellington JE, Whalley JM.

Vet Immunol Immunopathol. 2006 May 15;111(1-2):59-66. Epub 2006 Feb 13.

PMID:
16473414
6.

An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses.

Matsumura T, Kondo T, Sugita S, Damiani AM, O'Callaghan DJ, Imagawa H.

Virology. 1998 Mar 1;242(1):68-79.

7.

A review of equid herpesvirus 1 for the veterinary practitioner. Part A: clinical presentation, diagnosis and treatment.

Dunowska M.

N Z Vet J. 2014 Jul;62(4):171-8. doi: 10.1080/00480169.2014.899945. Review.

PMID:
24597778
8.

Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.

Patel JR, Földi J, Bateman H, Williams J, Didlick S, Stark R.

Vet Microbiol. 2003 Mar 20;92(1-2):1-17.

PMID:
12488066
10.

Potential of DNA-mediated vaccination for equine herpesvirus 1.

Ruitenberg KM, Walker C, Wellington JE, Love DN, Whalley JM.

Vet Microbiol. 1999 Aug 16;68(1-2):35-48.

PMID:
10501160
11.

The role of glycoprotein H of equine herpesviruses 1 and 4 (EHV-1 and EHV-4) in cellular host range and integrin binding.

Azab W, Zajic L, Osterrieder N.

Vet Res. 2012 Aug 21;43:61. doi: 10.1186/1297-9716-43-61.

13.

Equine herpesvirus infections in yearlings in South-East Queensland.

Diallo IS, Hewitson GR, de Jong A, Kelly MA, Wright DJ, Corney BG, Rodwell BJ.

Arch Virol. 2008;153(9):1643-9. doi: 10.1007/s00705-008-0158-y. Epub 2008 Aug 3.

PMID:
18677574
15.

Prevalence factors associated with equine herpesvirus type 1 infection in equids with upper respiratory tract infection and/or acute onset of neurological signs from 2008 to 2014.

Pusterla N, Mapes S, Akana N, Barnett C, MacKenzie C, Gaughan E, Craig B, Chappell D, Vaala W.

Vet Rec. 2016 Jan 16;178(3):70. doi: 10.1136/vr.103424. Epub 2015 Nov 25.

PMID:
26607427
16.

Detection of equine herpesvirus and differentiation of equine herpesvirus type 1 from type 4 by the polymerase chain reaction.

Wagner WN, Bogdan J, Haines D, Townsend HG, Misra V.

Can J Microbiol. 1992 Nov;38(11):1193-6.

PMID:
1335829
18.

Protective effects of intranasal immunization with recombinant glycoprotein d in pregnant BALB/c mice challenged with different strains of equine herpesvirus 1.

Fuentealba NA, Zanuzzi CN, Scrochi MR, Sguazza GH, Bravi ME, Cid de la Paz V, Corva SG, Portiansky EL, Gimeno EJ, Barbeito CG, Galosi CM.

J Comp Pathol. 2014 Nov;151(4):384-93. doi: 10.1016/j.jcpa.2014.06.003. Epub 2014 Aug 11.

PMID:
25124330
20.

Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.

Foote CE, Love DN, Gilkerson JR, Rota J, Trevor-Jones P, Ruitenberg KM, Wellington JE, Whalley JM.

Vet Immunol Immunopathol. 2005 May 1;105(1-2):47-57.

PMID:
15797474

Supplemental Content

Support Center